論文全著者名. 論題. 雑誌名. 発行年; 巻; :始頁-終頁

著者

Prognostic significance of serum cytokines during acute exacerbation of idiopathic interstitial
Arai T, Matsuoka H, Hirose M, Kida H, Yamamoto S, Ogata Y, Mori M, Hatsuda K, Sugimoto
pneumonias treated with thrombomodulin. BMJ Open Respir Res 2021 Jul; 8(1):e000889.
C, Tachibana K, Akira M, Inoue Y.
doi: 10.1136/bmjresp-2021-000889.
Oxygen Extraction Based on Inspiratory and Expiratory Gas Analysis Identifies Ventilatory
Miki K, Tsujino K, Maekura R, Matsuki T, Miki M, Hashimoto H, Kagawa H, Kawasaki T,Inefficiency in Chronic Obstructive Pulmonary Disease. Front Physiol 2021 Jul 28; 12:703977.
Kuge T, Kida H
doi: 10.3389/fphys.2021.703977.
Bevacizumab plus platinum-based chemotherapy in advanced non-squamous non-small-cell Udagawa H, Sugiyama E, Harada T, Atagi S, Koyama R, Watanabe S, Nakamura Y, Harada
lung cancer: A randomized, open-label phase 2 study (CLEAR). Transl Lung Cancer Res
D, Hataji O, Tanaka F, Kida H, Satouchi M, Maeno K, Inoue A, Yoh K, Yamane Y, Urata Y,2021 Jul; 10(7):3059-3070. doi: 10.21037/tlcr-21-240.
Yoshioka H, Yamanaka T, Goto K.
Serum GPL core antibody levels are associated with disease activity and treatment outcomes
Fukushima K, Kitada S, Matsumoto Y, Komukai S, Kuge T, Kawasaki T, Matsuki T, Motooka
in Mycobacterium avium complex lung disease following first line antibiotic treatments Respir
D, Tsujino K, Miki M, Miki K, Nakamura S, Kida H.
Med 2021 Oct; 187:106585. doi: 10.1016/j.rmed.2021.106585.
Impact of bronchial wall thickness on airflow obstruction in bronchiectasis. Respir Physiol
Yamamoto Y, Kuge T, Miki K, Tsujino K, Kawasaki T, Matsuki T, Miki M, Mori M, Kida H
Neurobiol 2022 Jan; 295:103788. doi: 10.1016/j.resp.2021.103788.
Takeuchi Y, Tanegashima T, Sato E, Irie T, Sai A, Itahashi K, Kumagai S, Tada Y, Togashi
Highly immunogenic cancer cells require activation of the WNT pathway for immunologicalY, Koyama S, Akbay EA, Karasaki T, Kataoka K, Funaki S, Shintani Y, Nagatomo I, Kida H,escape. Science Immunol 2021 Nov 12; 6 (65):eabc6424. doi: 10.1126/sciimmunol.abc6424. Ishii G, Miyoshi T, Aokage K, Kakimi K, Ogawa S, Okumura M, Eto M, Kumanogoh A, Tsuboi
M, Nishikawa H.
Pulmonary eosinophilia may indicate onset stage of allergic bronchopulmonary aspergillosis.
Miki M, Ohara Y, Tsujino K, Kawasaki T, Kuge T, Yamamoto Y, Matsuki T, Miki K, Kida HAllergy Asthma Clin Immunol. 2021 Nov 18; 17(1):118. doi: 10.1186/s13223-021-00624-4.
Pleural effusion caused by Mycolicibacterium mageritense in an immunocompetent host: aNiitsu T, Kuge T, Fukushima K, Matsumoto Y, Abe Y, Okamoto M, Haduki K, Saito H, Nitta
case report. Front Med (Lausanne) 2021 Nov 24; 8:797171. doi: 10.3389/fmed.2021.797171. T, Kawano A, Matsuki T, Motooka D, Tsujino K, Miki K, Nakamura S, Kida H, Kumanogoh A.
The diagnosis of nontuberculous mycobacterial pulmonary diasease by single bacterialKawasaki T, Kitada S, Fukushima K,Akiba E, Haduki K, Saito H, Nitta T, Kawano A, Miyazaki
isolation plus anti-GPL-core IgA antibody. Microbiol Spectr 2022 Feb 23; 10(1):e0140621. doi:A, Nii T, Kuge T, Koba T, Matsuki T, Tsujino K, Miki K, Maekura R, Kida H.
10.1128/spectrum.01406-21.
Advances and challenges of antibody therapeutics for refractory bronchial asthma. Int J Mol Abe Y, Suga Y, Fukushima K, Ohata H, Niitsu T, Nabeshima H, Nagahama Y, Kida H,Sci 2021 Dec 22; 23(1):83. doi: 10.3390/ijms23010083
Kumanogoh A.
呼吸器疾患からみた運動耐容能を高めるための換気能と酸素抽出能 The Japanese Journal of
三木 啓資
Rehabilitation Medicine 2022; 59(1):34-39.
わが国の肺NTM症の診断・治療に関する見解改訂に向けて 診断基準と治療開始基準 血清診断
木田博, 北田清悟, 前倉亮治を活かす可能性. 結核 2022; 97(3): 213-228.
Increased Oxygen Extraction by Pulmonary Rehabilitation Improves Exercise Tolerance andMiyazaki A, Miki K, Maekura R, Tsujino K, Hashimoto H, Miki M, Yanagi H, Koba T, Nii T,
Ventilatory Efficiency in Advanced Chronic Obstructive Pulmonary Disease. J Clin Med 2022
Matsuki T, Kida H
Feb 12; 11(4):963. doi: 10.3390/icm11040963.
Anti-myxovirus resistance protein-1 immunoglobulin A autoantibody in idiopathic pulmonary
Arai T, Hirose M, Hamano T, Kagawa T, Murakami A, Kida H, Kumanogoh A, Inoue Y.
fibrosis. Can Respir J 2022 Mar 29; 2022:1107673. doi: 10.1155/2022/1107673.
Specific targeting of lung ILC2 via NRP1 in pulmonary fibrosis. Cell Mol Immunol 2022 AprNii T, Fukushima K, Kida H.
22. doi: 10.1038/s41423-022-00867-0.
Long-term prognosis and anti-mycobacterial glycolipids antibody as biomarker in
Mycobacterium avium-intracellulare complex pulmonary disease. Microbiol Spectr 2022 Apr
25:e0053022. doi: 10.1128/spectrum.00530-22.

Maekura R, Kitada S, Miki K, Miki M, Tateishi Y, Matsumoto S, Kida H.

Mycobacterium senriese sp. nov., a slowly growing, non-scotochromogenic species, isolated
Abe Y, Fukushima K, Matsumoto Y, Niitsu T, Nabeshima H, Nagahama Y, Akiba E, Haduki
from sputum of elderly man. Int J Syst Evol Microbiol 2022 May; 72(5). doi:
K, Saito H, Kawano A, Matsuki T, Motooka D, Tsujino K, Miki K, Nakamura S, Kida H.
10.1099/ijsem.0.005378